As Caredx (CDNA) Market Value Declined, Holder Eam Investors Has Decreased by $1.66 Million Its Holding; Hourglass Capital Position in Ensco Plc (ESV) Decreased by $2.66 Million

Ensco plc (NYSE:ESV) Logo

Eam Investors Llc decreased its stake in Caredx Inc. (CDNA) by 41.39% based on its latest 2018Q3 regulatory filing with the SEC. Eam Investors Llc sold 59,391 shares as the company’s stock declined 1.56% with the market. The institutional investor held 84,110 shares of the health care company at the end of 2018Q3, valued at $2.43M, down from 143,501 at the end of the previous reported quarter. Eam Investors Llc who had been investing in Caredx Inc. for a number of months, seems to be less bullish one the $960.47 million market cap company. The stock decreased 3.64% or $0.89 during the last trading session, reaching $23.55. About 502,621 shares traded. CareDx, Inc (NASDAQ:CDNA) has risen 302.12% since February 13, 2018 and is uptrending. It has outperformed by 302.12% the S&P500. Some Historical CDNA News: 09/05/2018 – CareDx: Will Be Exclusive Worldwide Distributor of Illumina’s TruSight HLA Sequencing Panels and Associated Assign HLA Software; 01/05/2018 – CareDx Activities at American Transplant Congress; 09/03/2018 CareDx Short-Interest Ratio Rises 49% to 47 Days; 18/04/2018 – CareDx Closes Debt Refinancing; 09/05/2018 – CAREDX IN LICENSE & COMMERCIALIZATION PACT WITH ILLUMINA; 22/03/2018 – CareDx 4Q Loss $31.6M; 18/04/2018 – CAREDX SAYS ON APRIL 17 ENTERED INTO A CREDIT AGREEMENT AND GUARANTY – SEC FILING; 09/05/2018 – CareDx expands NGS Transplant Product Offerings; 13/04/2018 – Olerup QTYPE® Receives CE Mark Certification; 10/05/2018 – CareDx Sees FY18 Rev $64M-$66M

Hourglass Capital Llc decreased its stake in Ensco Plc (ESV) by 29.29% based on its latest 2018Q3 regulatory filing with the SEC. Hourglass Capital Llc sold 332,500 shares as the company’s stock declined 27.59% with the market. The hedge fund held 802,680 shares of the oil & gas production company at the end of 2018Q3, valued at $6.78 million, down from 1.14M at the end of the previous reported quarter. Hourglass Capital Llc who had been investing in Ensco Plc for a number of months, seems to be less bullish one the $1.95 billion market cap company. The stock increased 0.67% or $0.03 during the last trading session, reaching $4.48. About 6.87M shares traded. Ensco plc (NYSE:ESV) has declined 15.03% since February 13, 2018 and is downtrending. It has underperformed by 15.03% the S&P500. Some Historical ESV News: 25/04/2018 – ENSCO 1Q OPER REV. $417M, EST. $421.6M; 25/04/2018 – ENSCO 1Q ADJ LOSS/SHR CONT OPS 32C, EST. LOSS/SHR 27C; 22/05/2018 – Ensco plc Announces Cash Dividend; 25/04/2018 – Ensco 1Q Rev $417M; 13/04/2018 – Ensco Closes Above 200-Day Moving Average: Technicals; 25/04/2018 – Ensco 1Q Cont Ops Loss/Shr 32c; 25/04/2018 – Ensco 1Q Loss/Shr 32c; 26/03/2018 – Ensco Short-Interest Ratio Rises 18% to 8 Days; 14/05/2018 – Elephas Investment Buys New 1.9% Position in Ensco; 25/04/2018 – ENSCO 1Q LOSS/SHR CONT OPS 32C

Since November 14, 2018, it had 0 buys, and 1 insider sale for $27,990 activity.

Among 38 analysts covering Ensco Plc (NYSE:ESV), 12 have Buy rating, 5 Sell and 21 Hold. Therefore 32% are positive. Ensco Plc had 95 analyst reports since August 3, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Thursday, March 23 by Scotia Capital. As per Monday, September 19, the company rating was upgraded by Zephrin Group. The rating was upgraded by Clarksons Platou to “Neutral” on Thursday, September 22. On Thursday, October 19 the stock rating was initiated by HSBC with “Buy”. Guggenheim upgraded the stock to “Buy” rating in Monday, November 30 report. Susquehanna maintained Ensco plc (NYSE:ESV) on Friday, January 12 with “Hold” rating. The firm has “Market Perform” rating by Cowen & Co given on Thursday, January 7. The rating was upgraded by Susquehanna to “Neutral” on Tuesday, June 28. Deutsche Bank maintained the stock with “Sell” rating in Friday, July 31 report. The firm has “Hold” rating given on Tuesday, September 5 by Cowen & Co.

Investors sentiment increased to 1.11 in Q3 2018. Its up 0.26, from 0.85 in 2018Q2. It increased, as 22 investors sold ESV shares while 89 reduced holdings. 50 funds opened positions while 73 raised stakes. 391.43 million shares or 1.93% more from 384.01 million shares in 2018Q2 were reported. Greenlight Cap Inc reported 20.00M shares stake. Basswood Capital Management Lc reported 0% stake. Hourglass Cap Limited Liability Com has 1.76% invested in Ensco plc (NYSE:ESV). 20,959 were accumulated by Hsbc Public Ltd. Bancorporation Of Mellon reported 5.79 million shares. Hexavest Inc has invested 0% of its portfolio in Ensco plc (NYSE:ESV). Corecommodity Management Lc reported 24,126 shares. Brigade Capital Management Limited Partnership holds 1.30 million shares. Trexquant Invest LP has invested 0.17% in Ensco plc (NYSE:ESV). Pnc Ser Gp Inc holds 0% of its portfolio in Ensco plc (NYSE:ESV) for 22,308 shares. Willis Counsel has 1.19 million shares for 0.69% of their portfolio. Us Commercial Bank De accumulated 21,201 shares or 0% of the stock. Howe Rusling stated it has 700 shares or 0% of all its holdings. Gemmer Asset Ltd Liability Company stated it has 0% of its portfolio in Ensco plc (NYSE:ESV). Moreover, New York State Common Retirement Fund has 0.01% invested in Ensco plc (NYSE:ESV).

More notable recent Ensco plc (NYSE:ESV) news were published by: Seekingalpha.com which released: “Merger Arbitrage Mondays – February 4, 2019 – Seeking Alpha” on February 04, 2019, also Businesswire.com with their article: “Ensco plc Announces Intention to Adjourn General Meeting – Business Wire” published on January 17, 2019, Seekingalpha.com published: “Rowan: New 7-Well Contract, Details On Ensco Merger Negotiations – Seeking Alpha” on February 01, 2019. More interesting news about Ensco plc (NYSE:ESV) were released by: Seekingalpha.com and their article: “Rowan Ekes An Extra 24.2% Out Of Ensco – Seeking Alpha” published on February 01, 2019 as well as Globenewswire.com‘s news article titled: “Report: Developing Opportunities within Ensco plc, Third Point Reinsurance, Baxter International, Ultrapar Participacoes SA, Endeavour Silver, and Ingles Markets — Future Expectations, Projections Moving into 2019 – GlobeNewswire” with publication date: February 04, 2019.

Analysts await Ensco plc (NYSE:ESV) to report earnings on February, 25. They expect $-0.39 earnings per share, down 69.57% or $0.16 from last year’s $-0.23 per share. After $-0.33 actual earnings per share reported by Ensco plc for the previous quarter, Wall Street now forecasts 18.18% negative EPS growth.

Investors sentiment increased to 2.18 in 2018 Q3. Its up 0.36, from 1.82 in 2018Q2. It is positive, as 6 investors sold CDNA shares while 28 reduced holdings. 38 funds opened positions while 36 raised stakes. 28.20 million shares or 11.02% more from 25.40 million shares in 2018Q2 were reported. Manufacturers Life The stated it has 21,266 shares or 0% of all its holdings. Gagnon Advsrs Ltd Liability Corp holds 16.7% or 965,894 shares. Deutsche Bancorp Ag reported 283,579 shares or 0.01% of all its holdings. Aqr Cap Mngmt Limited Liability Co accumulated 0% or 170,198 shares. Bogle Invest Management Limited Partnership De invested in 78,839 shares or 0.16% of the stock. 1.24M are owned by Credit Suisse Ag. Perkins Cap Mgmt holds 3.66% or 211,060 shares. Awm Invest Inc holds 311,002 shares or 1.48% of its portfolio. Ameriprise Fincl Inc invested 0% of its portfolio in CareDx, Inc (NASDAQ:CDNA). Wells Fargo Mn holds 0% or 346,718 shares. Bridgeway Management holds 71,598 shares or 0.02% of its portfolio. Moreover, Barclays Public Limited has 0% invested in CareDx, Inc (NASDAQ:CDNA) for 24,109 shares. Eam Invsts Ltd Company reported 84,110 shares. Moreover, Millennium Mngmt Ltd Llc has 0% invested in CareDx, Inc (NASDAQ:CDNA) for 104,743 shares. Us Natl Bank De invested 0% in CareDx, Inc (NASDAQ:CDNA).

Among 5 analysts covering CareDx (NASDAQ:CDNA), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. CareDx had 18 analyst reports since September 25, 2015 according to SRatingsIntel. The firm earned “Market Perform” rating on Monday, September 28 by Raymond James. Mizuho maintained CareDx, Inc (NASDAQ:CDNA) rating on Tuesday, June 14. Mizuho has “Buy” rating and $8 target. H.C. Wainwright downgraded CareDx, Inc (NASDAQ:CDNA) rating on Tuesday, June 19. H.C. Wainwright has “Hold” rating and $1500 target. The firm has “Buy” rating given on Friday, September 25 by Craig Hallum. The stock of CareDx, Inc (NASDAQ:CDNA) has “Buy” rating given on Monday, January 8 by Piper Jaffray. The rating was upgraded by Raymond James on Wednesday, September 27 to “Outperform”. The firm earned “Buy” rating on Wednesday, June 6 by Piper Jaffray. Craig Hallum maintained the stock with “Buy” rating in Monday, October 9 report. The stock has “Buy” rating by H.C. Wainwright on Friday, May 11. The stock of CareDx, Inc (NASDAQ:CDNA) has “Buy” rating given on Monday, May 21 by Piper Jaffray.

Eam Investors Llc, which manages about $932.15 million and $672.79M US Long portfolio, upped its stake in Cryolife Inc. (NYSE:CRY) by 83,681 shares to 125,581 shares, valued at $4.42 million in 2018Q3, according to the filing. It also increased its holding in Natural Grocers By Vitamin Cottage Inc. (NYSE:NGVC) by 45,162 shares in the quarter, for a total of 112,013 shares, and has risen its stake in Kindred Biosciences Inc. (NASDAQ:KIN).

Analysts await CareDx, Inc (NASDAQ:CDNA) to report earnings on March, 28. They expect $-0.09 earnings per share, up 18.18% or $0.02 from last year’s $-0.11 per share. After $-0.54 actual earnings per share reported by CareDx, Inc for the previous quarter, Wall Street now forecasts -83.33% EPS growth.

More notable recent CareDx, Inc (NASDAQ:CDNA) news were published by: Nasdaq.com which released: “Horizon Discovery and Rutgers University form exclusive partnership to develop next generation novel gene editing technology – Nasdaq” on January 28, 2019, also Globenewswire.com with their article: “New Data on AlloSure Confirms Its Clinical Utility in Repeat Kidney Transplant Recipients – GlobeNewswire” published on December 20, 2018, Seekingalpha.com published: “CareDx, Inc. (CDNA) CEO Peter Maag on Q3 2018 Results – Earnings Call Transcript – Seeking Alpha” on November 10, 2018. More interesting news about CareDx, Inc (NASDAQ:CDNA) were released by: Globenewswire.com and their article: “CareDx Announces Completion of Debt Conversion Nasdaq:CDNA – GlobeNewswire” published on March 29, 2018 as well as Globenewswire.com‘s news article titled: “CareDx Reports Second Quarter Results Nasdaq:CDNA – GlobeNewswire” with publication date: August 09, 2018.

CareDx, Inc (NASDAQ:CDNA) Institutional Positions Chart